TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and ExpositionGlobeNewsWire • 12/03/21
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell TherapiesGlobeNewsWire • 12/02/21
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 11/10/21
TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and ExpositionGlobeNewsWire • 11/04/21
Wall Street Analysts Believe TScan Therapeutics, Inc. (TCRX) Could Rally 147%: Here's is How to TradeZacks Investment Research • 11/01/21
Wall Street Analysts See a 215% Upside in TScan Therapeutics, Inc. (TCRX): Can the Stock Really Move This High?Zacks Investment Research • 10/15/21
TScan Therapeutics Appoints Heather Savelle as Vice President, Investor RelationsGlobeNewsWire • 10/05/21
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines ConferenceGlobeNewsWire • 09/28/21
TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal OfficerGlobeNewsWire • 09/09/21
TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/02/21
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 08/19/21
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease SummitGlobeNewsWire • 07/21/21